Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Quick Stats
May 14, 202656.0
AI Score
HOLD0.27
Volume Ratio
Apr 30, 2026
Next Earnings
11
+ve Days (30d)
19
-ve Days (30d)
BMY Stock Summary
Last updated May 14, 2026
BMY is currently trading at $56.63, positioned above its 200-day moving average of $52.39, indicating a long-term uptrend. The stock has a 52-week range of $42.52 to $62.8864.
Technical Analysis: The 50-day moving average stands at $58.61, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 43.202, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.089, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BMY at 56.0/100 with a HOLD recommendation.
BMY (Bristol-Myers Squibb Co.) Indicators
Last updated May 14, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 43.202 |
| CMF (20) | -0.089 |
| ROC (10) | -6.759 |
| ADX (14) | 12.369 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.769 |
| AROONOSC (14) | -50.0 |
| WILLAMS %R (14) | -79.721 |
| MFI (14) | 34.075 |
BMY Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
BMY Price vs Max Options Open Interest
BMY Max Change In Options Open Interest
BMY Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BMY Daily Out of Money Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BMY Daily In the Money Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BMY Most Active Options by Volume(near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Bristol-Myers Squibb Co. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
BMY Moving Averages Analysis
Bristol-Myers Squibb Co. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on May 14, 2026
BMY (Bristol-Myers Squibb Co.) Simple Moving Averages
Moving Averages are last updated May 14, 2026
| Days | MA |
|---|---|
| 10 | 56.67 |
| 20 | 57.81 |
| 30 | 58.1 |
| 50 | 58.61 |
| 100 | 57.95 |
| 200 | 52.39 |
BMY Fundamental Analysis
| P/E (Forward) | 8.8968 |
| P/E (Trailing) | 15.726 |
| Market Cap ($) | 113.7 billion |
| Earnings/Share ($) | 3.54 |
| Net Proft Margin (%) | 0.1501 |
| Dividend/Share ($) | 2.5 |
| EPS Estimate Current Year ($) | 6.3032 |
| EPS Estimate Next Year ($) | 6.1473 |
| WallStreet Target Price ($) | 63.32 |
| Most Recent Quarter |